Data as of Jul 31
| -2.62 / -2.02%|
The 19 analysts offering 12-month price forecasts for Amgen Inc have a median target of 129.00, with a high estimate of 155.00 and a low estimate of 114.00. The median estimate represents a +1.26% increase from the last price of 127.39.
The current consensus among 23 polled investment analysts is to Buy stock in Amgen Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.